CSL Behring Australia
The role involves developing, validating, and conducting in vitro and ex vivo assays to evaluate novel biologic therapeutics, including recombinant antibodies, using human samples. The scientist will work on flow cytometry, functional cell-based assays, and molecular biology techniques to investigate target biology and therapeutic mechanisms, and will present findings to internal teams.
CSL Behring Australia is a biopharmaceutical leader driven by its promise to save and improve lives. We manufacture remedies for rare and serious conditions.
Headquarters
San Francisco, CA
Company Size
201-500 employees
Founded
2018
Industry
Technology
Glassdoor Rating
4.2 / 5
Sarah Johnson
Chief Executive Officer
Michael Chen
Chief Technology Officer
Emily Williams
VP of Engineering
David Rodriguez
VP of Product
Jessica Thompson
Chief Financial Officer
Andrew Park
VP of Sales
View leadership team, funding history,
and employee contacts for CSL Behring Australia.
CSL Behring Australia didn’t post a salary, so this is our estimate from similar listings.
21% above the average for this role
Principal Associate Scientist
Xaira Therapeutics
Postdoc
mountsinaihospital.com
Ceel & Gene Therapy Technical Development
Global Channel Management
Research Services Entry Laboratory Science Professional
University of Colorado
Associate Scientist, Toxicology II
AbbVie
(StealthCo) Scientist: Biology and Cell Pharmacology
Foresite Labs